From CHF Solutions’ new Italian distribution deal to Masimo’s CE Mark approval, here are five medtech stories we missed this week but thought were still worth mentioning. 1. CHF Solutions signs Italian distribution deal CHF Solutions announced in an April 17 press release that it has signed a new distribution agreement with TRX Italy to distribute […]
7 medtech stories we missed this week: April 6, 2018
From CHF Solutions’s distribution deal to Guided Therapeutics’s licensing agreement, here are seven medtech stories we missed this week but throught were still worth mentioning. 1. CHF inks Spanish distribution deal CHF Solutions announced in an April 5 press release that it has signed a distribution agreement with Dimedix Surgical. The distribution agreement will allow […]
Intersect ENT launches Sinuva steroid-releasing sinus implant
Intersect ENT (NSDQ:XENT) launched its steroid-releasing sinus implant, Sinuva, in the U.S. today. The company’s drug-eluting device is designed to treat nasal polyp disease in patients who have undergone previous sinus surgery. Sinuva is placed during a routine doctor’s office visit and releases an anti-inflammatory steroid, mometasone furoate, directly to the patient’s nasal polyps for up to […]
NuVasive touts Porous PEEK interbody implant study
NuVasive (NSDQ:NUVA) yesterday released results from a study of the company’s Porous PEEK material compared against titanium-coated PEEK and smooth PEEK material used in interbody fusion devices, touting advantages of its proprietary materials. Results from the study were published in The Spine Journal. In the study, researchers compared interbody implants composed of titanium-coated PEEK, smooth PEEK […]
Is 3D printing going to replace injection molding?
3D printing and injection molding each have their own benefits and limitations when it comes to making medical device parts, according to experts from PTI Engineered Plastics, Carbon and Protolabs. Medical device parts makers are increasingly turning to 3D printing, but additive manufacturing has yet to reach the tipping point where it could supplant injection molding […]
LivaNova wins expanded CE Mark labeling for Bicarbon aortic valve
LivaNova (NSDQ:LIVN) said today it won expanded CE Mark labeling for its Bicarbon aortic heart valves, now cleared for use with low-dose anticoagulant therapy. The new approval clears low risk patients who’ve received a Bicarbon aortic valve implant to be targeted using a lower international normalized ratio measurement of blood coagulability, allowing for a lower-range level […]
Reva touts first implant of Fantom Encore bioresorbable scaffold in Switzerland
Reva Medical (ASX:RVA) announced today that the company’s Fantom Encore bioresorbable vascular scaffold was used for the first time in Switzerland. The sirolimus-eluting device, which is made from Reva’s proprietary Tyrocore polymer, features a 95-micron strut profile and x-ray visibility. Get the full story at our sister site, Drug Delivery Business News.
Smith & Nephew can’t slip metal-on-metal hip implant MDL
A Maryland federal judge yesterday shot down a bid from Smith & Nephew (NYSE:SNN) to dismiss negligence, failure to warn and breach of warranty claims in a multi-district litigation case concerning the company’s Birmingham hip resurfacing metal-on-metal hip implant. London-based Smith & Nephew were looking to dismiss the case, stating that claims in the MDL were […]
Tela Bio lands $1m investment for surgical implants
Privately-held Tela Bio said this week that it landed a $1 million investment from ProMedica, a not-for-profit healthcare group serving northwest Ohio and southern Michigan. According to the deal, Tela Bio and ProMedica Innovations Venture Fund plan to strike a strategic relationship to educate surgical specialists at the ProMedica Hernia Center using Tela Bio’s regenerative surgical implants. […]
7 medtech stories we missed this week: March 23, 2018
From Medizone’s evaluation deal to Advantis Medical Imaging getting CE Mark approval, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Medizone inks AsepticSure evaluation deal with commercial cleaning products maker Innovasource Medizone announced in a March 22 press release that it has signed a product evaluation agreement with […]
Minor orthopedic implant market to be worth $2.2 billion by 2021, analysts say
The minor orthopedic replacement implant market will grow from $1.5 billion in 2017 to $2.2 billion in 2021, according to analysts from The Business Research Co.. The company’s Minor Orthopedic Replacement Implants report said the industry will experience an annual growth rate of over 7%, driven by a higher rate of arthritis and fractures. Osteoarthritis […]
- 1
- 2
- 3
- …
- 50
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
Google+